Renalytix (STU:2O90) Short Interest


STU:2O90 Renalytix PLC STU:2O90
12 GF Score
Price €2.70
GF Value €7.11
! 3 Warning Signs
View Full Analysis

What is Renalytix Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:2O90 vs VEEV, BTSG, TEM: Short Interest Comparison

For the Health Information Services subindustry, Renalytix's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renalytix Short Interest vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Renalytix's Short Interest distribution charts can be found below:

* The bar in red indicates where Renalytix's Short Interest falls into.


STU:2O90
12GF Score
Renalytix PLC STU:2O90
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Renalytix (STU:2O90) Overvalued in 2026?

Based on GuruFocus' analysis, Renalytix stock appears to be undervalued. The current stock price of €2.70 is trading 62% below its estimated GF Value™ of €7.11.

Key valuation signals for STU:2O90:

  • Short Interest:
  • GF Value™: €7.11 vs. price of €2.70 (62% below fair value)
  • GF Score™: 12/100 with 3 warning signs

No single metric tells the full story. See the STU:2O90 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Renalytix Business Description

Other Exchanges RENXF:USARENX:UK2O9:Germany
Address 2 Leman Street, London, GBR, E1W 9US
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease. Its product, KidneyIntelX, is designed to improve kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. The company's service, KidneyIntelX.dkd, enables the assessment of risk for early-stage chronic kidney disease progression. KidneyIntelX uses a proprietary algorithm combining blood-based biomarkers, inherited genetics, and electronic health record data to generate a patient risk score predicting rapid kidney function decline.
12GF Score

Get the complete analysis for STU:2O90

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.70
Price
€7.11
GF Value